Abstract
The treatment of differentiated follicular-derived thyroid cancer (papillary and follicular thyroid cancer) generally includes thyroidectomy with or without lymph node excision followed by adjuvant treatment with radioiodine for selected cases. Thyroidectomy requires knowledge of anatomy, avoidance of blood loss, identification and preservation of the recurrent laryngeal nerves, and preservation of viable parathyroid glands. The extent of surgery is dependent on the extent of disease as dictated by the primary tumor and the presence of metastatic cervical lymph nodes. This is tempered by demands of safety and avoidance of surgical complications. Accurate preoperative staging, including preoperative imaging with ultrasound which includes the lateral neck compartments to determine extent of disease, is paramount to performing the appropriate extent of surgery to reduce the risk of persistent disease. In experienced hands thyroidectomy has low complication rates which primarily include hypoparathyroidism related to devascularization of parathyroid tissue and voice dysfunction related to injury of the superior or recurrent laryngeal nerves. Postoperative hypoparathyroidism presents with symptoms of hypocalcemia which are typically transient and can be treated with calcium and vitamin D supplementation. Recurrent laryngeal nerve palsy related to neurapraxia will typically resolve over several months; however anatomic disruption of the nerve will result in permanent voice dysfunction. This chapter discusses the preoperative assessment, operative approach, and postoperative management of papillary and follicular thyroid cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- FNA:
-
Fine needle aspirate
- PTH:
-
Parathyroid hormone
References
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
Adam MA, Thomas S, Youngwirth L, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA. Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes? Ann Surg. 2016.
Al-Qurayshi Z, Robins R, Hauch A, Randolph GW, Kandil E. Association of surgeon volume with outcomes and cost savings following thyroidectomy: a national forecast. JAMA Otolaryngol Head Neck Surg. 2016;142(1):32–9.
Gourin CG, Tufano RP, Forastiere AA, Koch WM, Pawlik TM, Bristow RE. Volume-based trends in thyroid surgery. Arch Otolaryngol Head Neck Surg. 2010;136(12):1191–8.
Moon JH, Kim YI, Lim JA, Choi HS, Cho SW, Kim KW, Park HJ, Paeng JC, Park YJ, Yi KH, Park J, Kim SE, Chung JK. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results. J Clin Endocrinol Metab. 2013 Mar;98(3):1061–8.
Lee CY, Long KL, Eldridge RJ, Davenport DL, Sloan DA. Preoperative laryngoscopy in thyroid surgery: do patients’ subjective voice complaints matter? Surgery. 2014;156:1477–82.
Wong KP, Lang BH, Ng SH, Cheung CY, Chan CT, Lo CY. A prospective, assessor-blind evaluation of surgeon-performed transcutaneous laryngeal ultrasonography in vocal cord examination before and after thyroidectomy. Surgery. 2013;154:1158–64.
Carneiro-Pla D, Miller BS, Wilhelm SM, Milas M, Gauger PG, Cohen MS, Hughes DT, Solorzano CC. Feasibility of surgeon-performed transcutaneous vocal cord ultrasonography in identifying vocal cord mobility: a multi-institutional experience. Surgery. 2014;156:1597–602.
Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.
Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246:375–81.
Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988;104:954–62.
Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery. 1998;124:958–64.
Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg. 2014;38:68–79.
Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011;33:645–9.
Mendelsohn AH, Elashoff DA, Abemayor E, St John MA. Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg. 2010;136:1055–61. Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in lower high-risk papillary thyroid cancer. Ann Surg Oncol. 2005;12:81–9
Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM, Shaha A, Shah JP. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery. 2012;51:571–9.
Stoll SJ, Pitt SC, Liu J, Schaefer S, Sippel RS, Chen H. Thyroid hormone replacement after thyroid lobectomy. Surgery. 2009;146(4):554–8.
Higgins TS, Gupta R, Ketcham AS, Sataloff RT, Wadsworth JT, Sinacori JT. Recurrent laryngeal nerve monitoring versus identification alone on post-thyroidectomy true vocal fold palsy: a meta-analysis. Laryngoscope. 2011;121:1009–17.
Pisanu A, Porceddu G, Podda M, Cois A, Uccheddu A. System review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy. J Surg Res. 2014;188:152–61.
Fontenot TE, Randolph GW, Setton TE, Alsaleh N, Kandil E. Does intraoperative nerve monitoring reliably aid in staging of total thyroidectomies? Laryngoscope. 2015;125(9):2232–5.
Sritharan N, Chase M, Kamani D, Randolph M, Randolph GW. The vagus nerve, recurrent laryngeal nerve, and external branch of the superior laryngeal nerve have unique latencies allowing for intraoperative documentation of intact neural function during thyroid surgery after establishing a baseline action potential waveform and amplitude. Laryngoscope. 2015;125(2):E84–9.
Henry LR, Solomon NP, Howard R, Gurevich-Uvena J, Horst LB, Coppit G, Orlikoff R, Libutti SK, Shaha AR, Stojadinovic A. The functional impact on voice of sternothyroid muscle division during thyroidectomy. Ann Surg Oncol. 2008;15(7):2027–33.
Chung TK, Rosenthal EL, Porterfield JR, Carroll WR, Richman J, Hawn MT. Examining national outcomes after thyroidectomy with nerve monitoring. J Am Coll Surg. 2014;219(4):765–70. doi:10.1016/j.jamcollsurg.2014.04.013. Epub 2014 May 29
Yumoto E, Sanuki T, Kumai Y. Immediate recurrent laryngeal nerve reconstruction and vocal outcome. Laryngoscope. 2006;116(9):1657–61. PubMed PMID: 16954999. Su WF, Hsu YD, Chen HC, Sheng H. Laryngeal re-innervation by Ansa cervicalis nerve implantation for unilateral vocal cord paralysis in humans. J Am Coll Surg. 2007;204(1):64–72.
Reeve T, Thompson NW. Complications of thyroid surgery: how to avoid them, how to manage them, and their possible effect on the whole patient. World J Surg. 2000;24:971–5.
Carr AA, Yen TW, Fareau GG, Cayo AK, Misustin SM, Evans DB, Wang TS. A single parathyroid hormone level obtained 4 hours after total thyroidectomy predicts the need for postoperative calcium supplementation. J Am Coll Surg. 2014;219(4):757–64.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 The Author(s)
About this chapter
Cite this chapter
Hughes, D.T., Gauger, P.G. (2017). Surgical Treatment of Papillary and Follicular Thyroid Cancer. In: Mancino, A., Kim, L. (eds) Management of Differentiated Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-54493-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-54493-9_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54492-2
Online ISBN: 978-3-319-54493-9
eBook Packages: MedicineMedicine (R0)